Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
58.30
+1.22 (2.14%)
At close: May 14, 2026, 4:00 PM EDT
59.00
+0.70 (1.20%)
After-hours: May 14, 2026, 7:40 PM EDT

Corcept Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,2593,6885,2973,3592,1902,098
Market Cap Growth
-18.99%-30.38%57.70%53.35%4.41%-31.31%
Enterprise Value
5,7573,3204,9192,9901,7581,874
Last Close Price
58.3034.8050.3932.4820.3119.80
PE Ratio
145.0242.4440.9734.5523.3422.25
Forward PE
72.2555.5332.1132.6119.9521.01
PEG Ratio
-----1.50
PS Ratio
8.144.847.856.965.455.73
PB Ratio
9.605.697.796.634.365.58
P/TBV Ratio
10.616.458.417.164.696.64
P/FCF Ratio
52.1326.0127.0126.5418.2612.53
P/OCF Ratio
51.9925.9726.7126.5118.2012.49
EV/Sales Ratio
7.494.367.296.204.385.12
EV/EBITDA Ratio
-72.2735.7127.6115.4414.88
EV/EBIT Ratio
-74.1235.9227.8715.6115.06
EV/FCF Ratio
47.9223.4225.0823.6314.6611.19
Debt / Equity Ratio
0.010.010.01000
Debt / EBITDA Ratio
-1.430.130.050.000.010.00
Debt / FCF Ratio
0.080.040.040.000.010.00
Net Debt / Equity Ratio
-0.51-0.56-0.55-0.73-0.86-0.59
Net Debt / EBITDA Ratio
48.62-7.97-2.73-3.40-3.78-1.77
Net Debt / FCF Ratio
-2.74-2.58-1.92-2.91-3.59-1.33
Asset Turnover
0.930.910.920.800.800.74
Inventory Turnover
1.041.031.080.940.971.07
Quick Ratio
2.532.603.114.056.585.28
Current Ratio
2.862.923.354.396.895.60
Return on Equity (ROE)
7.36%15.01%23.81%21.05%23.11%25.03%
Return on Assets (ROA)
-3.89%8.01%16.38%15.17%19.52%22.51%
Return on Invested Capital (ROIC)
-10.21%21.78%51.37%79.72%84.17%93.83%
Return on Capital Employed (ROCE)
-1.23%6.54%22.51%20.87%25.39%27.65%
Earnings Yield
0.75%2.36%2.44%2.89%4.28%4.49%
FCF Yield
1.92%3.84%3.70%3.77%5.48%7.98%
Buyback Yield / Dilution
-0.16%-5.73%-1.56%3.64%7.94%-1.42%
Total Shareholder Return
-0.16%-5.73%-1.56%3.64%7.94%-1.42%
Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q